1. A case‐study of model‐informed drug development of a novel PCSK9 anti sense oligonucleotide. Part 1: First time in man to phase II. (1st October 2022) Authors: Knöchel, Jane; Nilsson, Catarina; Carlsson, Björn; Wernevik, Linda; Hofherr, Alexis; Gennemark, Peter; Jansson‐Löfmark, Rasmus; Isaksson, Rikard; Rydén‐Bergsten, Tina; Hamrén, Bengt; Rekić, Dinko Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 11:Number 12(2022) Page Start: 1569 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AZD8233 antisense oligonucleotide targeting PCSK9 does not prolong QT interval. Issue 11 (10th June 2022) Authors: Rekić, Dinko; Azarov, Ivan; Knöchel, Jane; Sokolov, Victor; Nilsson, Catarina; Wernevik, Linda; Han, David; Rydén‐Bergsten, Tina; Ebrahimi, Ahmad; Dota, Corina; Carlsson, Björn Journal: British journal of clinical pharmacology Issue: Volume 88:Issue 11(2022) Page Start: 4839 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical safety, tolerability, pharmacokinetics and effects on urinary electrolyte excretion of AZD9977, a novel, selective mineralocorticoid receptor modulator. (22nd April 2018) Authors: Erlandsson, Fredrik; Albayaty, Muna; Chialda, Ligia; Ericsson, Hans; Amilon, Carl; Nelander, Karin; Jansson‐Löfmark, Rasmus; Wernevik, Linda; Kjaer, Magnus; Bamberg, Krister; Hartleib‐Geschwindner, Judith Journal: British journal of clinical pharmacology Issue: Volume 84:Number 7(2018.) Page Start: 1486 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effect of AZD9977 and spironolactone on serum potassium in heart failure with preserved or mildly reduced ejection fraction, and renal impairment: A randomized trial. Issue 10 (20th August 2022) Authors: Squire, Iain B.; Gabrielsen, Anders; Greasley, Peter J.; Wernevik, Linda; Hartleib‐Geschwindner, Judith; Holden, Julie; Johansson, Susanne; Rudvik, Anna; Sánchez, José; Bamberg, Krister; Melin, Johanna; Whittaker, Andrew Journal: Clinical and translational science Issue: Volume 15:Issue 10(2022) Page Start: 2493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Safety, Tolerability, and Pharmacokinetics of the Mineralocorticoid Receptor Modulator AZD9977 in Healthy Men: A Phase I Multiple Ascending Dose Study. Issue 2 (30th October 2019) Authors: Whittaker, Andrew; Kragh, Åsa M.; Hartleib‐Geschwindner, Judith; Albayaty, Muna; Backlund, Anna; Greasley, Peter J.; Heijer, Maria; Kjaer, Magnus; Forte, Pablo; Unwin, Robert; Wernevik, Linda; Ericsson, Hans Journal: Clinical and translational science Issue: Volume 13:Issue 2(2020) Page Start: 275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗